This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Christopher Vinson Gemmiti: Innovator in Tissue Engineering
Introduction
Christopher Vinson Gemmiti is a notable inventor based in Jonesboro, GA (US). He has made significant contributions to the field of tissue engineering, particularly through his innovative designs and methodologies. His work focuses on developing advanced bioreactors that enhance tissue growth and conditioning.
Latest Patents
Gemmiti holds a patent for a bioreactor and methods for tissue growth and conditioning. This bioreactor is designed to create tissue constructs and condition tissue-engineered constructs, as well as harvested tissues, including cryopreserved tissues. The unique design of the bioreactor allows for both static and dynamic culture and conditioning. It features a dual-chamber system, with one chamber positioned above and another below the cells or constructs. This configuration enables the application of biochemical and biomechanical stimuli to both sides of the cells or constructs, promoting optimal tissue development.
Career Highlights
Christopher Vinson Gemmiti is affiliated with the Georgia Tech Research Corporation, where he continues to advance his research in tissue engineering. His work has garnered attention for its potential applications in regenerative medicine and biotechnology. With a focus on innovation, Gemmiti strives to improve the efficacy of tissue engineering processes.
Collaborations
Gemmiti collaborates with Robert Guldberg, a fellow researcher in the field. Their partnership enhances the research efforts at Georgia Tech Research Corporation, contributing to the advancement of tissue engineering technologies.
Conclusion
Christopher Vinson Gemmiti is a pioneering inventor whose work in bioreactor technology is shaping the future of tissue engineering. His innovative approaches and dedication to research are paving the way for advancements in regenerative medicine.
